共 279 条
- [11] Chen Y-X(2016)Mechanisms of drug resistance in colon cancer and its therapeutic strategies World J Gastroenterol 22 6876-80
- [12] Fang J-Y(2021)LEF1 silencing sensitizes colorectal cancer cells to oxaliplatin, 5-FU, and irinotecan Biomed Pharmacother 143 112091-94
- [13] Vasan N(2018)CLDN6 enhances chemoresistance to ADM via AF-6/ERKs pathway in TNBC cell line MDAMB231 Mol Cell Biochem 443 169-80
- [14] Baselga J(2021)Targeting tumor lineage plasticity in hepatocellular carcinoma using an anti-CLDN6 antibody-drug conjugate Sci Transl Med 13 eabb6282-11
- [15] Hyman DM(2013)Claudin-3 and claudin-4 regulate sensitivity to cisplatin by controlling expression of the copper and cisplatin influx transporter CTR1 Mol Pharmacol 83 85-37
- [16] Yanagisawa Y(2018)Decrease in paracellular permeability and chemosensitivity to doxorubicin by claudin-1 in spheroid culture models of human lung adenocarcinoma A549 cells Biochim Biophys Acta Mol Cell Res 1865 769-304
- [17] Maruta F(2006)Claudins: emerging targets for cancer therapy Expert Rev Mol Med 8 1-51
- [18] Iinuma N(2017)Anti-claudin 18.2 antibody as new targeted therapy for advanced gastric cancer J Hematol Oncol 10 105-6
- [19] Ishizone S(2017)Antibody targeting of claudin-1 as a potential colorectal cancer therapy J Exp Clin Cancer Res 36 89-46
- [20] Koide N(2018)Two-step senescence-focused cancer therapies Trends Cell Biol 28 723-12